This inventor holds 1 USPTO granted patent. Top assignee: Black Diamond Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Chris Roberts and Cancer-Treatment Innovation
Introduction
Chris Roberts is an inventor associated with Belmont, Massachusetts, and Black Diamond Therapeutics, Inc. His patent work includes a method involving quinazoline derivatives for cancer treatment.
Latest Patents
The supplied information lists one patent associated with Roberts: “Method of Treating Cancers with Alkyne Substituted Quinazoline Derivatives.” The patent concerns the use of alkyne-substituted quinazoline derivatives in cancer treatment. Roberts is credited with 1 patent in the information provided.
Career Highlights
Roberts is connected with Black Diamond Therapeutics, Inc., a company working in the biotechnology field. His listed patent reflects an area of research focused on potential therapeutic approaches to cancer.
Collaborations
The supplied information names Elizabeth Buck and Matthew O’Connor as Roberts’s coworkers. Their inclusion indicates professional connections within his work environment, though specific collaborative roles are not provided.
Conclusion
Chris Roberts’s listed patent links his work at Black Diamond Therapeutics, Inc. with research into cancer-treatment methods using quinazoline derivatives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile